Synaptogenix Inc (SNPX)

[InTheTrenches]

Posted on twitter by Zachary Prensky:

"At $CRL Cambridge, MA conference on pre-clin development. Ran into co peddling bryostatin, claims $NTRP failed b/c of poor choice of route admin (rerunning study using intranasal!!)"

Reply by Ari Isaacs:

"Not all that familiar with bryostatin, its MOA, or $NTRP, however the #Intranasal route of admin. can be a wise choice for many #CNS meds. We at #IPMED have a proprietary Intranasal drug delivery system that's shown an incredible ability to transport #drug directly to the #brain"

------------------

Not sure on the source of this, but if true, I'd like to see why NTRP has come to this conclusion.